Search

Your search keyword '"Dressler, C"' showing total 309 results
Start Over Author "Dressler, C"
309 results on '"Dressler, C"'

2. S3-Leitlinie: Klassifikation, Diagnostik und Therapie der Urtikaria

Author

Zuberbier, T., primary, Altrichter, S., additional, Bauer, S., additional, Brehler, R., additional, Brockow, K., additional, Dressler, C., additional, Fluhr, J., additional, Gaskins, M., additional, Hamelmann, E., additional, Kühne, K., additional, Merk, H., additional, Mülleneisen, N.K., additional, Nast, A., additional, Olze, H., additional, Ott, H., additional, Pleimes, M., additional, Ruëff, F., additional, Staubach-Renz, P., additional, Wedi, B., additional, and Maurer, M., additional

Published
2023
Full Text
View/download PDF

3. European guideline (EuroGuiDerm) on atopic eczema – part II: non‐systemic treatments and treatment recommendations for special AE patient populations

Author

Wollenberg, A., primary, Kinberger, M., additional, Arents, B., additional, Aszodi, N., additional, Avila Valle, G., additional, Barbarot, S., additional, Bieber, T., additional, Brough, H.A., additional, Calzavara Pinton, P., additional, Christen‐Zäch, S., additional, Deleuran, M., additional, Dittmann, M., additional, Dressler, C., additional, Fink‐Wagner, A.H., additional, Fosse, N., additional, Gáspár, K., additional, Gerbens, L., additional, Gieler, U., additional, Girolomoni, G., additional, Gregoriou, S., additional, Mortz, C.G., additional, Nast, A., additional, Nygaard, U., additional, Redding, M., additional, Rehbinder, E.M., additional, Ring, J., additional, Rossi, M., additional, Serra‐Baldrich, E., additional, Simon, D., additional, Szalai, Z.Z., additional, Szepietowski, J.C., additional, Torrelo, A., additional, Werfel, T., additional, and Flohr, C., additional

Published
2022
Full Text
View/download PDF

4. European guideline (EuroGuiDerm) on atopic eczema: part I – systemic therapy

Author

Wollenberg, A., primary, Kinberger, M., additional, Arents, B., additional, Aszodi, N., additional, Avila Valle, G., additional, Barbarot, S., additional, Bieber, T., additional, Brough, H.A., additional, Calzavara Pinton, P., additional, Christen‐Zäch, S., additional, Deleuran, M., additional, Dittmann, M., additional, Dressler, C., additional, Fink‐Wagner, A.H., additional, Fosse, N., additional, Gáspár, K., additional, Gerbens, L., additional, Gieler, U., additional, Girolomoni, G., additional, Gregoriou, S., additional, Mortz, C.G., additional, Nast, A., additional, Nygaard, U., additional, Redding, M., additional, Rehbinder, E.M., additional, Ring, J., additional, Rossi, M., additional, Serra‐Baldrich, E., additional, Simon, D., additional, Szalai, Z.Z., additional, Szepietowski, J.C., additional, Torrelo, A., additional, Werfel, T., additional, and Flohr, C., additional

Published
2022
Full Text
View/download PDF

5. AS PER PDF

Author

Nast, A., Dilleen, M., Liyanage, W., Aikman, L., Szczypa, P., and Dressler, C.

Published
2018
Full Text
View/download PDF

7. European S3‐Guideline on the systemic treatment of psoriasis vulgaris – Update Apremilast and Secukinumab – EDF in cooperation with EADV and IPC

Author

Nast, A., Spuls, P.I., van der Kraaij, G., Gisondi, P., Paul, C., Ormerod, A.D., Saiag, P., Smith, C.H., Dauden, E., de Jong, E.M., Feist, E., Jobling, R., Maccarone, M., Mrowietz, U., Papp, K.A., Reich, K., Rosumeck, S., Talme, T., Thio, H.B., van de Kerkhof, P., Werner, R.N., and Dressler, C.

Published
2017
Full Text
View/download PDF

13. The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria

Author

Zuberbier, T. Abdul Latiff, A.H. Abuzakouk, M. Aquilina, S. Asero, R. Baker, D. Ballmer-Weber, B. Bangert, C. Ben-Shoshan, M. Bernstein, J.A. Bindslev-Jensen, C. Brockow, K. Brzoza, Z. Chong Neto, H.J. Church, M.K. Criado, P.R. Danilycheva, I.V. Dressler, C. Ensina, L.F. Fonacier, L. Gaskins, M. Gáspár, K. Gelincik, A. Giménez-Arnau, A. Godse, K. Gonçalo, M. Grattan, C. Grosber, M. Hamelmann, E. Hébert, J. Hide, M. Kaplan, A. Kapp, A. Kessel, A. Kocatürk, E. Kulthanan, K. Larenas-Linnemann, D. Lauerma, A. Leslie, T.A. Magerl, M. Makris, M. Meshkova, R.Y. Metz, M. Micallef, D. Mortz, C.G. Nast, A. Oude-Elberink, H. Pawankar, R. Pigatto, P.D. Ratti Sisa, H. Rojo Gutiérrez, M.I. Saini, S.S. Schmid-Grendelmeier, P. Sekerel, B.E. Siebenhaar, F. Siiskonen, H. Soria, A. Staubach-Renz, P. Stingeni, L. Sussman, G. Szegedi, A. Thomsen, S.F. Vadasz, Z. Vestergaard, C. Wedi, B. Zhao, Z. Maurer, M.

Subjects
immune system diseases, parasitic diseases, education, skin and connective tissue diseases
Abstract

This update and revision of the international guideline for urticaria was developed following the methods recommended by Cochrane and the Grading of Recommendations Assessment, Development and Evaluation (GRADE) working group. It is a joint initiative of the Dermatology Section of the European Academy of Allergology and Clinical Immunology (EAACI), the Global Allergy and Asthma European Network (GA²LEN) and its Urticaria and Angioedema Centers of Reference and Excellence (UCAREs and ACAREs), the European Dermatology Forum (EDF; EuroGuiDerm), and the Asia Pacific Association of Allergy, Asthma and Clinical Immunology with the participation of 64 delegates of 50 national and international societies and from 31 countries. The consensus conference was held on 3 December 2020. This guideline was acknowledged and accepted by the European Union of Medical Specialists (UEMS). Urticaria is a frequent, mast cell–driven disease that presents with wheals, angioedema, or both. The lifetime prevalence for acute urticaria is approximately 20%. Chronic spontaneous or inducible urticaria is disabling, impairs quality of life, and affects performance at work and school. This updated version of the international guideline for urticaria covers the definition and classification of urticaria and outlines expert-guided and evidence-based diagnostic and therapeutic approaches for the different subtypes of urticaria. © 2021 GA²LEN. Allergy published by European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd.

Published
2022

14. European consensus‐based (S2k) Guideline on the Management of Herpes Zoster – guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV), Part 1: Diagnosis

Author

Werner, R.N., Nikkels, A.F., Marinović, B., Schäfer, M., Czarnecka‐Operacz, M., Agius, A.M., Bata‐Csörgő, Z., Breuer, J., Girolomoni, G., Gross, G.E., Langan, S., Lapid‐Gortzak, R., Lesser, T.H., Pleyer, U., Sellner, J., Verjans, G.M., Wutzler, P., Dressler, C., Erdmann, R., Rosumeck, S., and Nast, A.

Published
2017
Full Text
View/download PDF

15. European consensus‐based (S2k) Guideline on the Management of Herpes Zoster – guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV), Part 2: Treatment

Author

Werner, R.N., Nikkels, A.F., Marinović, B., Schäfer, M., Czarnecka‐Operacz, M., Agius, A.M., Bata‐Csörgő, Z., Breuer, J., Girolomoni, G., Gross, G.E., Langan, S., Lapid‐Gortzak, R., Lesser, T.H., Pleyer, U., Sellner, J., Verjans, G.M., Wutzler, P., Dressler, C., Erdmann, R., Rosumeck, S., and Nast, A.

Published
2017
Full Text
View/download PDF

20. Die Relevanz von Endpunkten aus Perspektive der Betroffenen: Ergebnisse der Befragung von Patient*innen und von Mitgliedern der Leitlinienkommission im Rahmen der Entwicklung der GRADE-Leitlinie zur Diagnostik und Therapie des Analkarzinoms

Author

Werner, RN, Gaskins, M, Dressler, C, Nast, A, Schaefer, C, Siegel, R, and Aigner, F

Subjects
ddc: 610, 610 Medical sciences, Medicine
Abstract

Hintergrund/Fragestellung: Eine standardisierte Methode zur Erhebung der Werte und Präferenzen von Patient*innen bei der Entwicklung von Leitlinien ist bisher nicht etabliert. Im Rahmen der Entwicklung der ersten deutschen evidenzbasierten Leitlinie zum Management des Analkarzinoms wurden[zum vollständigen Text gelangen Sie über die oben angegebene URL], Who cares? – EbM und Transformation im Gesundheitswesen; 22. Jahrestagung des Deutschen Netzwerks Evidenzbasierte Medizin

Published
2021
Full Text
View/download PDF

21. EuroGuiDerm Guideline on the systemic treatment of Psoriasis vulgaris – Part 2: specific clinical and comorbid situations

Author

Nast, A., primary, Smith, C., additional, Spuls, P.I., additional, Avila Valle, G., additional, Bata‐Csörgö, Z., additional, Boonen, H., additional, De Jong, E., additional, Garcia‐Doval, I., additional, Gisondi, P., additional, Kaur‐Knudsen, D., additional, Mahil, S., additional, Mälkönen, T., additional, Maul, J.T., additional, Mburu, S., additional, Mrowietz, U., additional, Reich, K., additional, Remenyik, E., additional, Rønholt, K.M., additional, Sator, P.G., additional, Schmitt‐Egenolf, M., additional, Sikora, M., additional, Strömer, K., additional, Sundnes, O., additional, Trigos, D., additional, Van Der Kraaij, G., additional, Yawalkar, N., additional, and Dressler, C., additional

Published
2021
Full Text
View/download PDF

22. The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria

Author

Zuberbier, T., primary, Aberer, Werner, primary, Asero, R., primary, Abdul Latiff, A. H., primary, Baker, D., primary, Ballmer-Weber, B., primary, Bernstein, J. A., primary, Bindslev-Jensen, C., primary, Brzoza, Z., primary, Buense Bedrikow, R., primary, Canonica, G. W., primary, Church, M. K., primary, Craig, T., primary, Danilycheva, I. V., primary, Dressler, C., primary, Ensina, L. F., primary, Gimenez-Arnau, A., primary, Godse, K., primary, Goncalo, M., primary, Grattan, C., primary, and Hebert, J., primary

Published
2021
Full Text
View/download PDF

23. EAACI/GA(2)LEN/EDF/WAO guidelines for the definition, classification, diagnosis and treatment of urticaria

Author

Zuberbier, T., Aberer, W., Asero, R., Latiff, A. H. Abdul, Baker, D., Ballmer-Weber, B., Bernstein, J. A., Bindslev-Jensen, C., Brzoza, Z., Bedrikow, R. Buense, Canonica, G. W., Church, M. K., Craig, T., Danilycheva V, I., Dressler, C., Ensina, L. F., Gimenez-Arnau, A., Godse, K., Goncalo, M., Grattan, C., Hebert, J., Hide, M., Kaplan, A., Kapp, A., Katelaris, C. H., Kocaturk, E., Kulthanan, K., Larenas-Linnemann, D., Leslie, T. A., Magerl, M., Mathelier-Fusade, P., Meshkova, R. Y., Metz, M., Nast, A., Nettis, E., Oude-Elberink, H., Rosumeck, S., Saini, S. S., Sanchez-Borges, M., Schmid-Grendelmeier, P., Staubach, P., Sussman, G., Toubi, E., Vena, G. A., Vestergaard, C., Wedi, B., Werner, R. N., Zhao, Z., and Maurer, M.

Published
2020

25. EuroGuiDerm Guideline on the systemic treatment of Psoriasis vulgaris – Part 1: treatment and monitoring recommendations

Author

Nast, A., primary, Smith, C., additional, Spuls, P.I., additional, Avila Valle, G., additional, Bata‐Csörgö, Z., additional, Boonen, H., additional, De Jong, E., additional, Garcia‐Doval, I., additional, Gisondi, P., additional, Kaur‐Knudsen, D., additional, Mahil, S., additional, Mälkönen, T., additional, Maul, J.T., additional, Mburu, S., additional, Mrowietz, U., additional, Reich, K., additional, Remenyik, E., additional, Rønholt, K.M., additional, Sator, P.G., additional, Schmitt‐Egenolf, M., additional, Sikora, M., additional, Strömer, K., additional, Sundnes, O., additional, Trigos, D., additional, Van Der Kraaij, G., additional, Yawalkar, N., additional, and Dressler, C., additional

Published
2020
Full Text
View/download PDF

29. Wytyczne EAACI/GA2LEN/EDF/WAO dotyczące definicji, klasyfikacji, diagnostyki i leczenia pokrzywki

Author

Zuberbier, T., primary, Aberer, W., additional, Asero, R., additional, Latiff, A., additional, Baker, D., additional, Ballmer-Weber, B., additional, Bernstein, J., additional, Bindslev-Jensen, C., additional, Brzoza, Z., additional, Bedrikow, R., additional, Canonica, G., additional, Church, M., additional, Craig, T., additional, Danilycheva, I., additional, Dressler, C., additional, Ensina, L., additional, Giménez-Arnau, A., additional, Godse, K., additional, Gonçalo, M., additional, Grattan, C., additional, Hebert, J., additional, Hide, M., additional, Kaplan, A., additional, Kapp, A., additional, Katelaris, C., additional, Kocatürk, E., additional, Kulthanan, K., additional, Larenas-Linnemann, D., additional, Leslie, T., additional, Magerl, M., additional, Mathelier-Fusade, P., additional, Meshkova, R., additional, Metz, M., additional, Nast, A., additional, Nettis, E., additional, Oude-Elberink, H., additional, Rosumeck, S., additional, Saini, S., additional, Sánchez-Borges, M., additional, Schmid-Grendelmeier, P., additional, Staubach, P., additional, Sussman, G., additional, Toubi, E., additional, Vena, G., additional, Vestergaard, C., additional, Wedi, B., additional, Werner, R., additional, Zhao, Z., additional, and Maurer, M., additional

Published
2020
Full Text
View/download PDF

33. Studies on the optimized fluorescence diagnosis of tumours by comparing 5-Ala induced xenofluorescence and autofluorescence intensities of a murine tumour-non tumour tissue system cultivated on the CAM

Author

Dressler, C., Ismail, M. S., Ströbele, S., Daskalaki, A., Philipp, C., Berlien, H.-P., Liebsch, M., Spielmann, H., Schöffl, Harald, editor, Spielmann, Horst, editor, Tritthart, Helmut A., editor, Cußler, Klaus, editor, Goetschel, Antoine F., editor, Gruber, Franz P., editor, and Reinhardt, Christoph A., editor

Published
1997
Full Text
View/download PDF

35. Angebote zu Systematic Reviews durch die Medizinische Bibliothek der Charité – Universitätsmedizin Berlin

Author

Dressler, Corinna

Subjects
charité – universitätsmedizin berlin, charité medical library, systematic review, adult education, Bibliography. Library science. Information resources, Medicine (General), R5-920
Abstract

Systematic reviews are a distinct research methodology focusing on systematically identifying, evaluating, and synthesizing all available studies. Since 2022, the Charité Medical Library has been offering a new course series that teaches the fundamental steps of conducting a systematic review.The structure of the course series follows the methodological steps undertaken when conducting a systematic review: 1) review types and research questions, 2) systematic literature search, 3) search and literature management, 4) protocol development, 5) assessment of methodological study quality, 6) data extraction and data analysis, 7) data synthesis, 8) review evaluation.This article provides an overview of the course content and learning objectives. Challenges that arose in the first run of the eight-part course series are explained and possible solutions are presented.

Published
2023
Full Text
View/download PDF

42. Diabetes and breast cancer among women with BRCA1 and BRCA2 mutations

Author

Bordeleau, L, Lipscombe, L, Lubinski, J, Ghadirian, P, Foulkes, Wd, Neuhausen, S, Ainsworth, P, Pollak, M, Sun, P, Narod, Sa, Hereditary Breast Cancer Clinical Study Group Collaborators: Lynch HT, Eisen, A, Mckinnon, W, Wood, M, Saal, H, Chudley, A, Robidoux, A, Kim Sing, C, Tung, N, Armel, S, Huzarski, T, Provencher, D, Lemire, E, Tulman, A, Llacuachaqui, M, Sweet, K, Gilchrist, D, Karlan, B, Kurz, R, Rosen, B, Demsky, R, Panchal, S, Couch, F, Elser, C, Manoukian, S, Daly, M, Cybulski, C, Gronwald, J, Byrski, T, Olapade, O, Stoppa Lyonnet, D, Weitzel, J, Mclennan, J, Meschino, W, Pasini, Barbara, Singer, C, Dressler, C, Metcalfe, K, Domchek, S, and Isaacs, C.

Subjects
Adult, Oncology, Cancer Research, medicine.medical_specialty, Genes, BRCA2, BRCA1, BRCA2, breast cancer, diabetes, Genes, BRCA1, Antineoplastic Agents, Breast Neoplasms, Risk Assessment, Biochemistry, Article, Diabetes mellitus genetics, Breast cancer, Risk Factors, Internal medicine, Diabetes Mellitus, medicine, Hyperinsulinemia, Humans, Genetic Predisposition to Disease, Risk factor, skin and connective tissue diseases, Aged, Aged, 80 and over, business.industry, Diabetes, Obstetrics and Gynecology, Cancer, Middle Aged, medicine.disease, Risk factors for breast cancer, Case-Control Studies, Mutation, Cancer research, Female, Breast disease, Risk assessment, business
Abstract

Women with a BRCA1 or BRCA2 mutation face a high lifetime risk of breast cancer.1 It is important to identify risk factors for breast cancer among genetically predisposed women, to devise strategies to minimize the risk. Several lines of evidence link diabetes and breast cancer.2,3 Insulin resistance and hyperinsulinemia, which predispose to diabetes, may increase the risk of breast cancer in the general population,4 and hyperinsulinemia may promote the growth of pre-existing breast neoplasms.5 Furthermore, a high body mass index (BMI) is a risk factor for both breast cancer recurrence and for insulin resistance.6–8 It is also of interest to establish whether diabetes (or any of the drugs used to treat diabetes) influences the risk of breast cancer in BRCA carriers. The risk of future diabetes may also be increased in women after a diagnosis of breast cancer.9 This risk may be mediated by common risk factors, such as high BMI or insulin resistance, or diabetes may be a late effect of breast cancer treatment. It is important to explore the impact of these factors on the risk of diabetes in women with BRCA mutations. In this cohort of BRCA carriers, we sought to determine whether diabetes increases the risk of breast cancer in BRCA carriers, and to identify risk factors for diabetes in this high-risk population.

Published
2010

44. European consensus-based (S2k) Guideline on the Management of Herpes Zoster - guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV), Part 2: Treatment

Author

Werner, R.N., primary, Nikkels, A.F., additional, Marinović, B., additional, Schäfer, M., additional, Czarnecka-Operacz, M., additional, Agius, A.M., additional, Bata-Csörgő, Z., additional, Breuer, J., additional, Girolomoni, G., additional, Gross, G.E., additional, Langan, S., additional, Lapid-Gortzak, R., additional, Lesser, T.H., additional, Pleyer, U., additional, Sellner, J., additional, Verjans, G.M., additional, Wutzler, P., additional, Dressler, C., additional, Erdmann, R., additional, Rosumeck, S., additional, and Nast, A., additional

Published
2016
Full Text
View/download PDF

45. European consensus-based (S2k) Guideline on the Management of Herpes Zoster - guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV), Part 1: Diagnosis

Author

Werner, R.N., primary, Nikkels, A.F., additional, Marinović, B., additional, Schäfer, M., additional, Czarnecka-Operacz, M., additional, Agius, A.M., additional, Bata-Csörgő, Z., additional, Breuer, J., additional, Girolomoni, G., additional, Gross, G.E., additional, Langan, S., additional, Lapid-Gortzak, R., additional, Lesser, T.H., additional, Pleyer, U., additional, Sellner, J., additional, Verjans, G.M., additional, Wutzler, P., additional, Dressler, C., additional, Erdmann, R., additional, Rosumeck, S., additional, and Nast, A., additional

Published
2016
Full Text
View/download PDF

46. Prioritizing topics in guideline development: results of a two‐phase online survey of dermatologist members of the EADV.

Author

Nast, A., Gaskins, M., Eisert, L., Werner, R. N., Dressler, C., Borradori, L., Marinovic, B., and Paul, C.

Abstract

Background: Most clinical guidelines in dermatology are encyclopaedic, covering a disease and its aetiology, diagnosis, treatment and prevention in their entirety. The usability and uptake of guideline recommendations might be improved by guidelines that are more concise and address specific questions ranked by users according to their perceived importance. Objective: To survey the largest association of dermatologists in Europe, identify which questions in their everyday practice they felt would benefit from short, evidence‐based guidance and rank these systematically. Methods: A two‐phase online survey using a structured ranking approach and the members directory of the European Academy of Dermatology and Venereology (EADV). Results: The first survey yielded 265 suggestions, indicating a response rate of 3.7%. We grouped all responses according to themes and subsequently combined these into a list of 35 broader topics. These were presented to all members of the EADV in the second survey (response rate: 9.7%), which yielded a list of the top 10 topics participants felt were most in need of guidance. The first three were 'Systemic drug treatment in dermatology during pregnancy and for women wishing to have children in the near future', 'alopecia areata' and 'interpretation of laboratory results in connective tissue diseases'. Conclusion: Our two‐phase survey of EADV members and a structured ranking process were practical to implement and yielded a list of the top 10 topics in dermatology and venereology for guideline development. Guideline dissemination needs to be improved, and practical, more concise guidelines may facilitate efforts to do so. [ABSTRACT FROM AUTHOR]

Published
2019
Full Text
View/download PDF

49. European evidence-based (S3) guideline for the treatment of acne - update 2016 - short version

Author

Nast, A., primary, Dréno, B., additional, Bettoli, V., additional, Bukvic Mokos, Z., additional, Degitz, K., additional, Dressler, C., additional, Finlay, A.Y., additional, Haedersdal, M., additional, Lambert, J., additional, Layton, A., additional, Lomholt, H.B., additional, López-Estebaranz, J.L., additional, Ochsendorf, F., additional, Oprica, C., additional, Rosumeck, S., additional, Simonart, T., additional, Werner, R.N., additional, and Gollnick, H., additional

Published
2016
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results